Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Neonatal Hyperbilirubinemia by NeoprediX B.1 Algorithm - Prospective Observational Study -

NCT05121311 is registered in ClinicalTrials.gov with NeoPredix AG as lead sponsor.

NCT NCT05121311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05121311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Neonatal Hyperbilirubinemia by NeoprediX B.1 Algorithm - Prospective Observational Study -
Lead sponsor
NeoPredix AG
Phase
Observational
Overall status
Completed
Start date
August 9, 2021
Completion date
January 31, 2022
Enrollment
455 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

newborn jaundice